• Expertise
  • Ingredient Solutions
  • Applications
  • Resources
    Resources
  • PLT People & Planet
  • About
    About

    Our international network, passionate team of experts and extensive industry knowledge is what sets us apart.

    Seth circle headshot
    Seth Flowerman
    President and CEO

5-LOXIN®

Improved Joint Comfort and Flexibility within 7 Days!
5-loxin-logo

OVERVIEW

5-LOXIN® is one of the world’s best-selling joint health ingredients – with multiple clinical studies that demonstrate efficacy starting at 7 days – with a low dose.

product-5loxin-7days-1

7 Days

5-LOXIN has been shown in clinical trials to improve joint comfort in as little as 7 days.

phytoshield-ingredients

100mg

Proven efficacy at only 100mg/day.

product-synapsa-studies-1

15 Studies

5-LOXIN is supported by 13 preclinical and 2 human clinical trials.

FEATURES & BENEFITS

 

Both 100mg and 250mg doses improves joint comfort and mobility

Studies show improvement within 7 days

Standardized to 30% AKBA

Thirteen preclinical and two human clinical studies

Significant benefits in WOMAC, VAS and LFI testing

Impacts biological markers associated with joint and general health IL-6

Supported by extensive safety data

5loxin-feature-and-benefit-1

CERTIFICATIONS

Vegan Icon

VEGAN

cert-icons-cert-gluten-free-1

GLUTEN-FREE

cert-icons-cert-non-gmo-1

NON-GMO

cert-icons-cert-halal-1

HALAL

cert-icons-cert-kosher-1

KOSHER

A Patented, Synergistic Extract of Boswellia serrata

 5-LOXIN is a patented, clinically studied dietary supplement ingredient. Boswellic acids are natural, selective 5-lipoxygenase inhibitors. 3-O-acetyl-11-keto-ß-boswellic acid or “AKBA” is the most active.

Boswellia serrata

Sourced from the forests of India, Boswellia has been used in Ayurvedic medicine for thousands of years.

5loxin-ingredient-circle

 

Generational harvesting

Boswellia serrata trees are handed down in Indian families as a source of wealth and income.  

Rhodiola rosea

Rhodiola rosea is a plant native to remote Arctic climates in Asia, Europe and North America.

rhodiolife-rhodiola-1

 

Exciting Phytochemistry

The root of the plant contains around 140 chemical compounds including phenols, rosavin, rosarin, salidroside and more.

Detail 1

Kale chips cold-pressed put a bird on it mumblecore kogi brooklyn farm-to-table blue bottle yuccie authentic kombucha migas. Literally tilde tacos paleo.

turmeric-curry-moringa-oleifera-ingredient-slendacor

 

Detail 2

Kale chips cold-pressed put a bird on it mumblecore kogi brooklyn farm-to-table blue bottle yuccie authentic kombucha migas. Literally tilde tacos paleo.

RESEARCH

Fifteen Studies and Counting

5-LOXIN has been the subject of 13 pre-clinical studies and 2 human clinical trials. One of the key features of 5-LOXIN in any formulation is clinical work that has demonstrated efficacy starting at 7 days – at a significantly lower dose (100 mg) than other joint health ingredients. Efficacy was shown in Visual Analog Score (VAS), Lequesne Functional Index (LFI) and Western Ontario and McMaster Universities Arthritis Index (WOMAC) pain, stiffness and function evaluations.


Beyond joint comfort and flexibility improvements, 5-LOXIN also positively impacts biological markers associated with joint health and inflammation, including TNFa, CRP, and IL-6. It was also shown to significantly inhibit matrix metalloproteinase (MMP-3), enzymes that break down cartilage, collagen and connective tissues.

CLINICAL HIGHLIGHTS

Clinical Study: 5-LOXIN Improves Joint Comfort and Physical Function 

5-loxin Improves Joint Comfort and Physical Function chart

A 75 subject,  90-day, double-blind, randomized, placebo-controlled study was conducted to evaluate the efficacy and safety of 5-LOXIN in the treatment of osteoarthritis (OA) of the knee. Subjects  received either 100 mg (n = 25) or 250 mg (n = 25) of 5-Loxin daily or a placebo. At the end of the study, both doses of 5-Loxin conferred clinically and statistically significant improvements in pain scores and physical function scores in OA patients.

Sengupta K, Alluri KV, Satish AR, et al. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Arthritis Res Ther. 2008;10(4):R85. doi:10.1186/ar2461

GET THE RESULTS

5-loxin Improves Joint Comfort and Physical Function chart

Clinical Study: 5-LOXIN Reduces Joint Pain Starting at 7 Days

5-LOXIN clinical - image only

A 90-day, double-blind, randomized, placebo-controlled study was conducted to evaluate the comparative efficacy and tolerability of 5-Loxin(®) and Aflapin(®) in the treatment of osteoarthritis (OA) of the knee. Sixty OA subjects received either 100 mg (n=20) of 5-Loxin® or 100 mg (n=20) of Aflapin® or a placebo (n=20) daily for 90 days. Each patient was evaluated for pain and physical functions by using the standard tools.

Krishanu Sengupta, et al Int J Med Sci 2010 Nov 1;7(6):366-77. doi: 10.7150/ijms.7.366.

GET THE RESULTS

5-LOXIN clinical - image only
ACCESS CLINICAL STUDIES

MARKET OPPORTUNITIES

icon-bones

Bone, Joint & Muscle Health

Multiple clinical studies on 5-LOXIN demonstrate efficacy starting at 7 days – with a low dose.

icon-aging

Healthy Aging

Today’s seniors travel more, play more and do more than ever. 5-LOXIN can help them get moving and keep moving.

icon-active-con

Active/Sports Nutrition

Inflammation from exercise has similarities to the type of inflammation that occurs with the aging process.

icon-weight

Weight Management

5-LOXIN can help your customers succeed in achieving their weight management goals by giving them the freedom to workout.

APPLICATIONS

app-capsules

CAPSULES

effervescent icon new

EFFERVESCENTS

app-powders

POWDERS

app-softgels

SOFT GELS

app-stickpacks

STICK PACKS

app-tablets

TABLETS

ORIGIN STORY

It Starts with Boswellia

Boswellia serrata, native to India, is one of 19 species of the genus Boswellia. PLT Boswellia-based ingredients are sourced only from select regions of India.

5loxin-origin-story-2

A Storied Past

The plant resin of the Boswellia tree provides a commercial oil known as frankincense, which has a “woody, spicy and haunting smell.” It is possibly best known through the biblical story of the Three Wise Men, who delivered gifts of gold, frankincense, and myrrh.

5loxin-origin-story-5

Careful Harvesting

The harvest of Boswellia oleo gum resin occurs through “wounding and healing” of the tree, termed “tapping,” shallow debarking the tree to expose resin glands and stimulate resin production. Harvest is stopped from May through October or November in order to allow a period for tree recovery.

Boswellia oleo gum resin tree_crop

Exacting Analytics

Boswellia serrata oleo gum resin extracts are evaluated for unique characteristic features. Laila Nutraceuticals has developed an identification method using fingerprint profiles and high-performance thin-layer chromatography (HPTLC) and high-performance liquid chromatography (HPLC).

5loxin-quality-crop

State-of-the-Art Processing

Laila Nutraceuticals facilities maintain third-party Good Manufacturing Practices (GMP) certification from NSF International. The NSF certification includes compliance to the U.S. FDA Food Safety Modernization Act (FSMA) and cGMP 21 CFR 117 + 21 CFR 111.

3-1

QUALITY

Boswellia resin_iStock-1169502987

From Harvest to Finished Ingredient


The starting point for 5-LOXIN – Boswellia serrata – is a plant that produces Indian frankincense. It is also known as Indian olibanum, Salai guggul, and Sallaki in Sanskrit. The plant is native to much of India and the Punjab region that extends into Pakistan. In partnership with Laila, PLT is committed to the safety and fair treatment of the people who harvest 5-LOXIN. We want to support the long-term health and well-being of the tribal culture and the natural environment upon which it relies.

Every batch of the 5-LOXIN harvest is assigned a specific batch number, and each batch of finished product is traced to a specific region and set of trees. 5-LOXIN is tested and must comply with predefined specifications for different parameters at different stages of product manufacturing – from raw materials to finished product. Quality is monitored by a multi-disciplinary organization with dedicated departments for taxonomy (botanical Identification), raw material analysis, chemical analysis, microbiology, and more.

SUSTAINABILITY

Understanding the Difference Makes the Difference


During the fourth quarter of 2021, PLT Health Solutions announced the commencement of a third-party sustainability audit program on Boswellia serrata trees, which serve as the raw material source for some of our most important ingredients. The audit of this India resource was conducted by renowned botanical research consultancy Botanical Liaisons, LLC, and was undertaken to help the nutraceutical industry and non-governmental agencies around the world understand what we and our ingredient innovation partner Laila Nutraceuticals have known for many years: proper stewardship of natural resources and social responsibility toward the communities that support our work are both the right thing to do and good business.


The audit program was a step in PLT’s campaign to document the sustainability of the tree resource. PLT’s Chairman, Paul Flowerman, made field trips to the key production areas in 2018 and 2019 to observe and document the variety of tree populations, methods of natural and forced propagation and the status of the tribal groups involved in the care of the trees and resin production.

AKBA Ingredient_Sustainability Image_1

5loxin-origin-story-1

 

A third audit program was based on a broad range of environmental, cultural and economic parameters. In March 2022 Botanical Liaisons reported to PLT its preliminary conclusions, which included this statement: “It is clear from the information collected from the stakeholders that [sustainability] is supported. Boswellia serrata has several sustainability advantages that prevent over-harvesting of PLT-sourced Boswellia compared to other sources and species of Boswellia.” The report recommended a series of next steps to further evaluate and promote sustainability. 


Subsequently, four important additional developments have added considerable strength to the Boswellia serrata sustainability story:

  1. Authoritative tree survey data from Madhya Pradesh quantified the robustness and sufficiency of the tree resource to provide present and future resin requirements.
  2. CITES (Convention on International Trade in Endangered Species of Wild Fauna and Flora) determined during its November 2022 meeting (COP 19 in Panama City) that no Boswellia species would get added to the CITES Appendix lists. The health of Boswellia serrata, the only species of commercial importance for PLT, was documented, including information about the replenishment of the resource.
  3. AHPA (American Herbal Products Association) convened an expert panel, which has drafted a brochure entitled, “Good Stewardship Harvesting of Boswellia (Boswellia Serrata).” This is a definitive presentation of current best practices.
  4. An important study modeling the impact of significant climate change by 2050 on Boswellia serrata resources predicted that almost all of Madhya Pradesh, the source of 90+% of commercial resin, will remain conducive for a healthy tree population.

These initiatives represent the type of work we do with our PLT360™ initiative. Introduced in 2015, our PLT360 initiative is a business-wide commitment by PLT Health Solutions to develop ingredients that our customers can be confident and proud to supply to their own customers – knowing that these ingredients are safe, of high quality, efficacious and harvested and manufactured sustainably. PLT360 examines every business decision and business process we undertake to be transparent with our operations, build trust with the health & well-being community and, together with them, support healthier, happier lives for the consumers we serve. 

INSIGHTS

PLT Mobility Solutions 

At PLT, we are working on the concept of Mobility Solutions - making these solutions available for people of all ages and walks of life. We’re thinking about athletes who want to perform better and recover faster. We’re thinking about people who have physically demanding jobs who don’t want to or can’t take a day off from work. We’re thinking about anyone who has an active lifestyle who wants to embrace it despite the rigors. And yes, we’re thinking about the global aging population. 


PLT Health Solutions’ leading portfolio of mobility support ingredients – based on more than a decade of ongoing research – has been developed to help you deliver innovative products that can capture the attention and the trust of consumers. All of our ingredients are backed by multiple clinical studies – and offer rapid improvements from a low dose - in just about any delivery system you can imagine.

5loxin-quality-1-mobility solutions

 

5loxin-quote

“We worship and protect these trees and this tradition is also passed on from generation to generation.”

Collector in Madhya Pradesh

RESOURCES

Logo
5-LOXIN® Product Sheet
March 20, 2020
Behind every ingredient solution is an even better story, download the product sheet to learn more.
Industry NewsSales Collateral
view
Logo
PLT to Launch Novel Cognitive Performance, Joint Health, and Cardiovascular Support Ingredients at Vitafoods Europe 2023
April 11, 2023

PLT Health Solutions, Inc is launching a new breakthrough ingredient called Nutricog® Cognitive Performance Complex at Vitafoods Europe on 9 May at Booth G135. 

Industry NewsPress Releases
read more